Prognostic Value of Cystatin C on Admission in Heart Failure With Preserved Ejection Fraction (original) (raw)

Trace Protein and Cystatin C as Predictors of Long-Term Outcomes in Patients With Acute Heart Failure

Journal of The American College of Cardiology, 2011

Usefulness of Cystatin C and Prognosis Following Admission for Acute Heart Failure

The American Journal of Cardiology, 2009

Cystatin C as Marker of Cardiorenal Syndrome and Poor Prognosis in Patients Hospitalized with Acute Heart Failure and Normal Renal Function

CARLOS FEDERICO VARELA

2016

View PDFchevron_right

Cystatin C as a Predictor of Mortality and Cardiovascular Events in a Population with Chronic Kidney Disease

milagros ortiz

International Journal of Nephrology, 2014

View PDFchevron_right

The impact of admission cystatin C levels on in-hospital and three-year mortality rates in acute decompensated heart failure

Hatice Selcuk

Cardiovascular journal of Africa, 2018

View PDFchevron_right

Cystatin C concentration as a predictor of systolic and diastolic heart failure

Andrew Moran

2008

View PDFchevron_right

Cystatin C is correlated with mortality in patients with and without acute kidney injury

Erland Löfberg

Nephrology Dialysis Transplantation, 2009

View PDFchevron_right

Cystatin C as a predictor for outcomes in patients with negligible renal function

Li-chun Ho

Blood purification, 2014

View PDFchevron_right

Cystatin C: a step forward in assessing kidney function and cardiovascular risk

Johan Lassus

Heart Failure Reviews, 2012

View PDFchevron_right

Limited Value of Cystatin-C over Estimated Glomerular Filtration Rate for Heart Failure Risk Stratification

Paloma Gastelurrutia, Josep Lupón

PLoS ONE, 2012

View PDFchevron_right

Cystatin C as an early marker of acute kidney injury and predictor of mortality in the intensive care unit after acute myocardial infarction

Mohamed Fouad

Arab journal of nephrology and transplantation, 2013

View PDFchevron_right

Cystatin C: A prognostic marker after myocardial infarction in patients without chronic kidney disease

Leila Abid

Journal of the Saudi Heart Association, 2016

View PDFchevron_right

Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)

Luc Djoussé

American Heart Journal, 2008

View PDFchevron_right

Increased urinary cystatin C indicated higher risk of cardiovascular death in a community cohort

Axel Carlsson

Atherosclerosis, 2014

View PDFchevron_right

Can Serum Cystatin C predict long-term survival in cardiac surgery patients?

Michele Ferrannini

Aging, 2018

View PDFchevron_right

Serum Cystatin C-A Useful Endogenous Marker of Renal Function in Intensive Care Unit Patients at Risk for or with Acute Renal Failure?

Peter Spronk, Lieuwe Hofstra

Current Medicinal Chemistry, 2007

View PDFchevron_right

Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function

Sebastjan Bevc

2006

View PDFchevron_right

Cystatin C and Long-Term Mortality Among Subjects With Normal Creatinine-Based Estimated Glomerular Filtration Rates

Cho-Kai Wu

Journal of the American College of Cardiology, 2010

View PDFchevron_right

Utility of Cystatin C for Assessment of Renal Function after Cardiac Surgery

Priv.-Doz. Dr. Reiner M . Waeschle

Nephron Clinical Practice, 2009

View PDFchevron_right

Presurgical Serum Cystatin C and Risk of Acute Kidney Injury After Cardiac Surgery

Amit Garg

American Journal of Kidney Diseases, 2011

View PDFchevron_right

Serum Cystatin C as a predictor of cardiac surgery associated-acute kidney injury in patients with normal preoperative renal functions. A prospective cohort study

Mohamed Samy

The Egyptian Journal of Critical Care Medicine, 2017

View PDFchevron_right

Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome

Johan Lassus

European Heart Journal, 2010

View PDFchevron_right

Serum Cystatin C as an Endogenous Marker of Renal Function in Patients with Chronic Kidney Disease

Sebastjan Bevc

Renal Failure, 2008

View PDFchevron_right

Serum Cystatin C as a Biomarker of Cardiac Diastolic Dysfunction in Patients With Cardiac Disease and Preserved Ejection Fraction

Masayuki Doi

Congestive Heart Failure, 2013

View PDFchevron_right

Plasma Concentrations of Cystatin C in Patients with Coronary Heart Disease and Risk for Secondary Cardiovascular Events: More than Simply a Marker of Glomerular Filtration Rate

Hermann Iats

View PDFchevron_right

Early detection of acute renal failure by serum cystatin C

Onno Janssen

Kidney International, 2004

View PDFchevron_right

Serum cystatin C level as a potentially good marker for impaired kidney function

Hafize Uzun

Clinical Biochemistry, 2005

View PDFchevron_right

Cystatin-C serum levels and vascular function in heart failure

Evangelos Oikonomou

International Journal of Cardiology, 2014

View PDFchevron_right

Cystatin C and Its Temporal Change May Predict Development and Recovery of Cardio-renal Syndrome Type 1 in Acute Heart Failure

Ajar Koçak

e-Journal of Cardiovascular Medicine

View PDFchevron_right

Cystatin C in Prediction of Acute Kidney Injury: A Systemic Review and Meta-analysis

Zhongheng Zhang

American Journal of Kidney Diseases, 2011

View PDFchevron_right

Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care

Urban Alehagen

European Journal of Heart Failure, 2009

View PDFchevron_right

Prognostic Value of Cystatin C on Admission in Heart Failure With Preserved Ejection Fraction (original) (raw)

Related papers